|
|
|
| Title | Authors | Drug | Fish species | Date | Efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibriosis in cod (Gadus morhua). |
Samuelsen OB, Bergh O |
Oxolinic acid |
Cod, Atlantic |
2004 | Efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibriosis in cod (Gadus morhua). |
Samuelsen OB, Bergh O |
Oxolinic acid |
Cod, Atlantic |
2004 | Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo. |
Rigos G, Tyrpenou AE, Nengas I, Alexis AEM, Athanassopoulou, Troisi GM |
Oxytetracycline |
Seabream, sharpsnout |
2004 | Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo. |
Rigos G, Tyrpenou AE, Nengas I, Alexis AEM, Athanassopoulou, Troisi GM |
Oxytetracycline |
Seabream, sharpsnout |
2004 | Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo. |
Rigos G, Tyrpenou AE, Nengas I, Alexis AEM, Athanassopoulou, Troisi GM |
Oxytetracycline |
Seabream, sharpsnout |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-dead |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-dead |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-dead |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-dead |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-healthy |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-healthy |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-healthy |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-healthy |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-moribund |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-moribund |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-moribund |
2004 | Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar). |
Coyne R, Bergh O, Samuelsen O, Andersen K, Lunestad BT, Nilsen H, Dalsgaard I, Smith P |
Oxolinic acid |
Salmon, Atlantic-moribund |
2004 | A comparison of oxolinic acid concentrations in farmed and laboratory held rainbow trout (Oncorhynchus mykiss) following oral therapy. |
Coyne R, Samuelsen O, Kongshaug H, Andersen K, Dalsgaard I, Smith P, Bergh O. |
Oxolinic acid |
Trout, rainbow |
2004 | A comparison of oxolinic acid concentrations in farmed and laboratory held rainbow trout (Oncorhynchus mykiss) following oral therapy. |
Coyne R, Samuelsen O, Kongshaug H, Andersen K, Dalsgaard I, Smith P, Bergh O. |
Oxolinic acid |
Trout, rainbow |
2004 | A comparison of oxolinic acid concentrations in farmed and laboratory held rainbow trout (Oncorhynchus mykiss) following oral therapy. |
Coyne R, Samuelsen O, Kongshaug H, Andersen K, Dalsgaard I, Smith P, Bergh O. |
Oxolinic acid |
Trout, rainbow |
2004 | A comparison of oxolinic acid concentrations in farmed and laboratory held rainbow trout (Oncorhynchus mykiss) following oral therapy. |
Coyne R, Samuelsen O, Kongshaug H, Andersen K, Dalsgaard I, Smith P, Bergh O. |
Oxolinic acid |
Trout, rainbow |
2004 | On the validity of setting breakpoint minimum inhibition concentrations at one quarter of plasma concentration achieved following oral administration of oxytetracycline. |
Coyne R, Samuelsen O, Bergh O, Andersen K, Pursell L, Dalsgaard I, Smith P |
Oxytetracycline |
Salmon, Atlantic-healthy |
2004 | On the validity of setting breakpoint minimum inhibition concentrations at one quarter of plasma concentration achieved following oral administration of oxytetracycline. |
Coyne R, Samuelsen O, Bergh O, Andersen K, Pursell L, Dalsgaard I, Smith P |
Oxytetracycline |
Salmon, Atlantic-laboratory |
2004 | A question of temperature related differences in plasma oxolinic acid concentrations achieved in rainbow trout (Oncorhynchus mykiss) under laboratory conditions following multiple oral dosing. |
Coyne R, Bergh O, Smith P, Samuelsen O. |
Oxolinic acid |
Trout, rainbow |
2004 | Relationship between blood and muscle levels of astaxanthin in dosal aorta cannulated Atlantic Salmon. |
Kiessling A, Dosanjh B, Koppe W, Higgs D |
Astaxanthin |
Salmon, Atlantic |
2006 | Relationship between blood and muscle levels of astaxanthin in dosal aorta cannulated Atlantic Salmon. |
Kiessling A, Dosanjh B, Koppe W, Higgs D |
Astaxanthin |
Salmon, Atlantic |
2006 | Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). |
Xu W, Zhu X, Wang X, Deng L, Zhang G |
Enrofloxacin |
Shrimp, Chinese |
2006 | Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). |
Xu W, Zhu X, Wang X, Deng L, Zhang G |
Enrofloxacin |
Tilapia, Nile |
2006 | Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). |
Xu W, Zhu X, Wang X, Deng L, Zhang G |
Enrofloxacin |
Tilapia, Nile |
2006 | Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). |
Xu W, Zhu X, Wang X, Deng L, Zhang G |
Enrofloxacin |
Tilapia, Nile |
2006 | Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). |
Xu W, Zhu X, Wang X, Deng L, Zhang G |
Furazolidone |
Tilapia, Nile |
2006 | Pharmacokinetics of oxytetracycline in black tiger shrimp, Penaeus monodon, and the effect of cooking on the residues. |
Uno K, Aoki T, Kleechaya W, Tanasomwang V, Ruangpan L. |
Oxytetracycline |
Shrimp, giant tiger prawn (black tiger) |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-onfillet tissue after exposure to AQUI-S at different temperatures, durations and concentrations. |
Meinertz JR, Greseth SL, Schreier TM, Bernardy JA, Gingerich WH |
Isoeugenol |
Trout, rainbow |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Conger, European |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Crab spp. |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Crab, European green |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Crab, hermit |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Lobster, rugose squat |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Mussel, blue |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Sculpin, shorthorn |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Shark, small-spotted catshark (dogfish) |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Starfish, common |
2006 | Environmental effects of the anti-sea lice (Copepoda: Caligidae therapeutant emamectin benzoate under commercial use conditions in the marine environment. |
Telfer TC, Baird DJ, McHenery JG, Stone J, Sutherland I, Wislocki P |
Emamectin |
Whelk, waved |
2006 | Pharmacokinetics and the active metabolite of enrofloxacin in Chinese mitten-handed crab (Eriocheir sinensis). |
Tang J, Yang X-l, Zheng Z-l, Yu W-j, Hu K, Yu H-j |
Enrofloxacin |
Crab, Chinese mitten-handed |
2006 | Pharmacokinetics and the active metabolite of enrofloxacin in Chinese mitten-handed crab (Eriocheir sinensis). |
Tang J, Yang X-l, Zheng Z-l, Yu W-j, Hu K, Yu H-j |
Enrofloxacin |
Crab, Chinese mitten-handed |
2006 | |
|
Prev
|
Next
|
70
|
71
|
[72]
|
73
|
74
|
First
|
Last
|
All
|
|
|
|
|